OptimizeRx Corp(OPRX)— Stock Profile, AI Score & Financials

Industrials · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

OptimizeRx Corp (OPRX) stock profile, AI quality score, and SEC EDGAR financial data, a Industrials sector company. 13F Pro's AI-powered ranking engine scores OPRX at 57.4/100 on a 32-signal composite quality model, placing it at rank #1,104 of 2,960 stocks — the top half of the AI-ranked universe. OPRX scores in the top quartile across earnings quality (86.6), revenue growth (79.7). Areas of concern include institutional flow (3.7) and revenue scale (15.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 21.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), OptimizeRx Corp reports quarterly revenue of $20.5M, net income of $-703.0K, free cash flow of $8.6M. Top institutional holders of OPRX by reported 13-F value include Whetstone Capital Advisors, ROYCE & ASSOCIATES, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. OPRX trades on the Nasdaq exchange and files with the SEC under CIK 1448431. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OPRX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for OptimizeRx Corp directly from SEC EDGAR.